Valuation for a Specialty Finance Company (Equity DCF or DDM?)

A client of ours is looking to invest a significant minority stake in a diversified specialty finance company. Half of their income comes from purchasing and selling factoring receivables (so like most non-banks, the company is highly leveraged, since they need the debt to purchase the receivables) and the other half is fee-based income. In this case, I think it's best to calculate the equity value, instead of EV, but I was wondering which is more common in the case of a non-bank, specialty finance company. There's no regulated capital like banks, so if I were to do DDM, then I would also have to come up with a rationale on whether to set a minimum capital ratio for the projections or just have all of the Net Income back into the dividends issued. Equity DCF (FCFE) sounds more reasonable for non-banks but projecting the debt servicing/capex for FCFE sounds difficult (please correct me if I'm wrong).

If anyone has done valuation of a non-bank/specialty finance company, could you please explain how you valued the company? Also, if anyone has ever done an lbo model for a specialty finance company, any explanation regarding differences between that and a regular company would be much appreciated.

Any advice, tips, etc. would be helpful. Thanks in advance!

2 Comments
 
Best Response

You want to use a DDM for specialty finance companies(BS lenders).

If it is a more mature company I would look at the historical debt to equity ratio and keep that constant. Another option would be to look at the debt covenants and figure it out that way.

However you figure out what the minimum equity needed you will need to make sure that base is satisfied and pay the rest of the earnings out as a dividend.

I have only built out on full lbo model for a spec fin company so I am not sure if my experience would be helpful but my one point of advice is to pay attention to the debt needed to run the business and the amount of debt a sponsor can actually put on the business.

 

Pariatur quos eos nemo repudiandae fugiat corrupti ex et. Nobis inventore nobis maxime impedit aspernatur maxime. Molestiae quo saepe inventore aspernatur perspiciatis. Cumque quidem quo repudiandae.

Omnis aperiam et ut ut quasi. Aperiam dolorum nostrum autem ab modi. Expedita laborum in quia est. Id ut et non exercitationem modi deserunt. Aut cum sed magnam voluptatem fuga autem temporibus. Quo et eius inventore aut et. Ab rerum reprehenderit aut dolores aut autem.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Guggenheim Partners 01 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 03 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”